Chemoinformaics analysis of 1,8-P-Menthadien-9-Yl-Acetate
| Molecular Weight | 194.274 | nRot | 3 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 8 |
| Exact Molecular Weight | 194.131 | nRing | 1 |
| Solubility: LogS | -3.03 | nHRing | 0 |
| Solubility: LogP | 3.231 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.6463 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.51 |
| Synth | 3.321 |
| Natural Product Likeliness | 2.27 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.373 |
| MDCK | 0.0000244 |
| BBB | 0.995 |
| PPB | 0.689646 |
| VDSS | 1.433 |
| FU | 0.307833 |
| CYP1A2-inh | 0.662 |
| CYP1A2-sub | 0.105 |
| CYP2c19-inh | 0.19 |
| CYP2c19-sub | 0.47 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.483 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.452 |
| CYP3a4-inh | 0.082 |
| CYP3a4-sub | 0.264 |
| CL | 6.955 |
| T12 | 0.532 |
| hERG | 0.005 |
| Ames | 0.803 |
| ROA | 0.088 |
| SkinSen | 0.16 |
| Carcinogencity | 0.949 |
| EI | 0.822 |
| Respiratory | 0.893 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.655494 |